Company / Gross Profit per Share
Veracyte, Inc. Gross Profit per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$4.66
FY2025
5-year range
$2.47 / $4.66
FY2022-FY2025
Trend
+14.5%
vs FY2024
Sector context
#69 of 94
Health Care
What the data says
At $4.66, Veracyte, Inc.'s gross profit per share ranks #69 of 94 in the Health Care sector. Gross Profit per Share has increased for 3 consecutive years, from $2.47 in FY2022 to $4.66 in FY2025.
Based on SEC 10-K filings.
4.66 in FY2025 with a 3-year CAGR of +23.6%.
Improved from $3.19 to $4.66 over the past 2 years.
Health Care sector context is included.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- +23.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#69 of 94 in Health CareTop 73% of 94This company $4.66 Sector average $14.29
▼
-67.4% below sector average
Key checks
Key Insights
- Veracyte, Inc.'s gross profit per share has grown for 3 consecutive years.
- In FY2025, gross profit per share increased 14.5% year-over-year.
- Ranks #69 out of 94 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 6.19 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.66 | +14.5% |
| FY2024 | $4.07 | +27.5% |
| FY2023 | $3.19 | +29.2% |
| FY2022 | $2.47 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026